Olaratumab-induced Biomarker Modulation in Sarcomas-Letter

Mol Cancer Ther. 2021 Oct;20(10):2093. doi: 10.1158/1535-7163.MCT-21-0413.

Authors

Vicente Valenti¹, Alberto Carmona-Bayonas², Paula Jimenez-Fonseca³, Ramon Salazar⁴

Affiliations

¹ Baix Penedès County Hospital, El Vendrell, Tarragona, Spain. vvalenti@xarxatecla.cat.
² Hospital General Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain.
³ Hospital Universitario Central de Asturias, Servicio De Salud, Del Principado De Asturias, Oviedo, Asturias, Spain.
⁴ Institut Català d'Oncologia, Catalan Department of Health, Barcelona, Spain.

PMID: 34607901
DOI: 10.1158/1535-7163.MCT-21-0413

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal*
Biomarkers
Humans
Sarcoma*

Substances

Antibodies, Monoclonal
Biomarkers
olaratumab